XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.
XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.
XOMA特许股份交易价格上涨，因公司宣布对Seralutinib的经济利益，这是一项研究肺动脉高压的第3阶段资产。
XOMA Royalty Shares Are Trading Higher After the Company Announced Its Economic Interest in Seralutinib, a Phase 3 Asset Studying Pulmonary Arterial Hypertension.
XOMA Royalty Shares在公司宣布其对Seralutinib的经济利益后交易上涨，Seralutinib是一个研究肺动脉高压的三期资产。